Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

被引：1
|
作者：
Patel, V. [1 ]
Mcphail, M. J. W. [1 ]
Zamalloa, A. [1 ]
Stoy, S. [1 ,2 ]
Vijay, G. M. [1 ]
Huang, X. [1 ]
Rogers, G. [3 ]
Choo, J. [3 ]
Edwards, L. [1 ]
Gray, E. [1 ]
Woodhouse, C. [1 ]
Gencer, S. [4 ]
Coen, M. [4 ]
Wendon, J. [1 ]
Bruce, K. [5 ]
Shawcross, D. [1 ]
机构：
[1] Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, James Black Ctr,Liver Sci, 1st Floor, London, England
[2] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark
[3] South Australian Hlth & Med Res Inst, Microbiome Res, Adelaide, SA, Australia
[4] Imperial Coll London, Dept Surg & Canc, Div Computat & Syst Med, Biomol Med, London, England
[5] Kings Coll London, Inst Pharmaceut Sci, 5th Floor Franklin Wilkins Bldg, London, England
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30432-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LBP-005
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [41] Effect of Punica granatum Extract Supplementation in Patients With Liver Cirrhosis: A Randomised, Double-Blind, Placebo-Controlled Trial☆
    Namdar, A. B.
    Ghafouridehgolan, F.
    Rakhshandeh, H.
    Sanaei, H.
    Jarrahi, L.
    Mohammadmousaei, F.
    Rajabian, A.
    JOURNAL OF HERBAL MEDICINE, 2023, 42
  • [42] Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial
    Tashkin, DP
    Kanner, R
    Bailey, W
    Buist, S
    Anderson, P
    Nides, MA
    Gonzales, D
    Dozier, G
    Patel, MK
    Jamerson, BD
    LANCET, 2001, 357 (9268): : 1571 - 1575
  • [43] Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
    Prantera, C
    Lochs, H
    Campieri, M
    Scribano, ML
    Sturniolo, GC
    Castiglione, F
    Cottone, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1117 - 1125
  • [44] Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind randomised, placebo-controlled trial
    Reginster, J-Y
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (02) : E8 - E8
  • [45] Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
    Lorena Brance, Maria
    ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (02) : 225 - 227
  • [46] Efficacy and Safety of Strontium Ranelate in the Treatment of Knee Osteoarthritis: Results of a Double-Blind, Randomised Placebo-Controlled Trial
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (01): : 22 - 22
  • [47] Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
    Murphy, Claire-Louise
    Murphy, Eithne
    Duffy, Trevor
    O'Sullivan, Miriam
    Barry, Maurice
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : E13 - E13
  • [48] EFFICACY AND SAFETY OF PRUCALOPRIDE IN MEN WITH CHRONIC CONSTIPATION: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Yiannakou, Y.
    Bouchoucha, M.
    Schiefke, I.
    Piessevaux, H.
    Filip, R.
    Gabalec, L.
    Stephenson, D.
    Kerstens, R.
    Etherson, K.
    Levine, A.
    GUT, 2015, 64 : A323 - A324
  • [49] A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
    Rinella, Mary E.
    Lieu, Hsiao D.
    Kowdley, Kris V.
    Goodman, Zachary D.
    Alkhouri, Naim
    Lawitz, Eric
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Wong, Vincent Wai-Sun
    Younes, Ziad H.
    Sheikh, Aasim M.
    Brannan, Donald
    Freilich, Bradley
    Membreno, Fernando
    Sinclair, Marie
    Melchor-Khan, Liza
    Sanyal, Arun J.
    Ling, Lei
    Harrison, Stephen A.
    HEPATOLOGY, 2024, 79 (03) : 674 - 689
  • [50] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    Wallace, Daniel J.
    Furie, Richard A.
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle A.
    Doerner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    Carmack, Tara
    DeLozier, Amy M.
    Janes, Jonathan M.
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    LANCET, 2018, 392 (10143): : 222 - 231
12345